Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNB4 | O00305 | 15/20 | 0.42 |
| ▸ | CACNA1A | O00555 | 15/20 | 0.42 |
| ▸ | CACNA1G | O43497 | 15/20 | 0.42 |
| ▸ | CACNG3 | O60359 | 15/20 | 0.42 |
| ▸ | CACNA1F | O60840 | 15/20 | 0.42 |
| ▸ | CACNA1H | O95180 | 15/20 | 0.42 |
| ▸ | CACNB3 | P54284 | 15/20 | 0.42 |
| ▸ | CACNA2D1 | P54289 | 15/20 | 0.42 |
| ▸ | CACNG7 | P62955 | 15/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 15/20 | 0.42 |
| ▸ | CACNA1D | Q01668 | 15/20 | 0.42 |
| ▸ | CACNB1 | Q02641 | 15/20 | 0.42 |
| ▸ | CACNG1 | Q06432 | 15/20 | 0.42 |
| ▸ | CACNB2 | Q08289 | 15/20 | 0.42 |
| ▸ | CACNA1S | Q13698 | 15/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 15/20 | 0.42 |
| ▸ | CACNA1E | Q15878 | 15/20 | 0.42 |
| ▸ | CACNA2D4 | Q7Z3S7 | 15/20 | 0.42 |
| ▸ | CACNA2D3 | Q8IZS8 | 15/20 | 0.42 |
| ▸ | CACNG8 | Q8WXS5 | 15/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5148949 | 0.86 | FYN (0.48) | FYNMGLL | |
| SCHEMBL5148867 | 0.85 | MDM2 (0.46) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| Hydrochloric Acid SCHEMBL5150749 | 0.83 | CACNB4 (0.39) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL5147758 | 0.81 | FYN (0.45) | CACNA1BFYNMGLL | |
| SCHEMBL5149184 | 0.81 | FYN (0.44) | CACNA1BFYNMGLL | |
| SCHEMBL5152228 | 0.81 | PDE4A (0.40) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL5147718 | 0.80 | FYN (0.43) | FYNMGLL | |
| SCHEMBL6687338 | 0.80 | PTGS1 (0.42) | FYNPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL5147735 | 0.79 | CACNB4 (0.39) | CACNB4CACNA1ACACNA1GCACNG3CACNA1F | |
| SCHEMBL5148802 | 0.78 | FYN (0.46) | FYNMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567503-B1 | PYRAZOLE DERIVATIVES USEFUL AS COX-I INHIBITORS | ASTELLAS PHARMA INC (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20070112037-A1 | Pyrazole Derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-7183306-B2 | Pyrazole derivatives | ASTELLAS PHARMA INC. (JP) | 2007-02-27 | — | — | US | disclosed |
| EP-1567503-A1 | PYRAZOLE DERIVATIVES USEFUL AS COX-I INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004050632-A1 | PYRAZOLE DERIVATIVES USEFUL AS COX-I INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-17 | — | — | WO | disclosed |
| US-20040116475-A1 | Pyrazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112037-A1 | Pyrazole Derivatives | CYP11B2, CYP11B1, CYP3A43 | CACNB4 1907/4885CACNA1A 231/4885CACNA1G 1371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.